Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data

Abstract Background Since the results of the ToGA trial were published, trastuzumab-based chemotherapy has been used as the standard first-line treatment for HER2-positive recurrent or primary metastatic gastric cancer (RPMGC). However, the real-world data has been rarely reported. Therefore, we inv...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Tae-Hwan Kim, Hun Do Cho, Yong Won Choi, Hyun Woo Lee, Seok Yun Kang, Geum Sook Jeong, Jin-Hyuk Choi, Mi Sun Ahn, Seung-Soo Sheen
Format:	Article
Language:	English
Published:	BMC 2021-03-01
Subjects:	Trastuzumab Chemotherapy Gastric cancer Prognosis
Online Access:	https://doi.org/10.1186/s12885-021-08058-2